![(3R,11bR)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F1811-3r-11br-1346711b-hexahydro-910-dimethoxy-3-2-methylpropyl-2h-benzo-a-quinolizin-2-one.webp&w=3840&q=75)
CAS 1026016-83-0: (3R,11bR)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one
Formula:C19H27NO3
InChI:InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1
InChI key:InChIKey=MKJIEFSOBYUXJB-GDBMZVCRSA-N
SMILES:O(C)C=1C=C2[C@@]3(N(C[C@@H](CC(C)C)C(=O)C3)CCC2=CC1OC)[H]
Synonyms:- (+)-Tbz
- (+)-Tetrabenazine
- (3R,11BR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one
- (3R,11bR)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one
- (3R,11bR)-TBZ
- (3R,11bR)-Tetrabenazine
- 2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)-
Sort by
Found 10 products.
(3R,11bR)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one
CAS:Purity:95.0%Molecular weight:317.4289855957031Ref: 10-F497477
5mgTo inquire10mgTo inquire25mgTo inquire50mgTo inquire100mgTo inquire250mgTo inquire(3R,11bR)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one
CAS:Formula:C19H27NO3Purity:95%Color and Shape:SolidMolecular weight:317.4226(3R,11bR)-Tetrabenazine-d3
CAS:(3R,11bR)-Tetrabenazine-d3 is a racemic form of tetrabenazine that can be used as a molecular imaging agent. It is synthesized by reacting dihydroisoquinoline with hexane in the presence of malonate and an asymmetric synthesis. The product is purified by crystallization with methanol and analyzed using analytical methods such as gas chromatography or mass spectrometry. (3R,11bR)-Tetrabenazine-d3 has been shown to be effective for the treatment of Parkinson's disease and hyperkinetic movement disorders. It is also used to treat neuroleptic malignant syndrome and other conditions caused by dopamine-producing cells in the brain. Tetrabenazine binds to dopamine receptors on cells in the brain, blocking the effects of dopamine and reducing muscle rigidity, tremors, restlessness, and slowing movements. This drug also has a stereogenic center which means itFormula:C19H25D3NO3Purity:Min. 95%Molecular weight:320.44 g/mol(3R,11bR)-Tetrabenazine-d3
CAS:Controlled ProductFormula:C19D3H24NO3Color and Shape:NeatMolecular weight:320.441(3R,11bR)-Tetrabenazine
CAS:Controlled ProductFormula:C19H27NO3Color and Shape:NeatMolecular weight:317.42(+)-Tetrabenazine
CAS:(+)-Tetrabenazine ((3R,11bR)-Tetrabenazine) is a reversible vesicular monoamine transporter 2 (VMAT-2) inhibitor, inhibits transport by VMAT2 with 10-foldFormula:C19H27NO3Purity:98.31%Color and Shape:SolidMolecular weight:317.42
![(3R,11bR)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb%2FF497477.jpg&w=3840&q=75)
![(3R,11bR)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA0007VL.jpg&w=3840&q=75)
